A5061111317- Prenatal Substance Exposure Effects
- Opioid Use Disorder Treatment
- Maternal Mental Health During Pregnancy and Postpartum
- Toxic Organic Pollutants Impact
- Grief, Bereavement, and Mental Health
- Effects and risks of endocrine disrupting chemicals
- Treatment of Major Depression
- Adolescent and Pediatric Healthcare
- Homelessness and Social Issues
- Pregnancy and preeclampsia studies
- Neonatal and fetal brain pathology
- Maternal and fetal healthcare
- Maternal and Perinatal Health Interventions
- Poisoning and overdose treatments
- Ethics in Clinical Research
- Autopsy Techniques and Outcomes
- Cardiovascular Issues in Pregnancy
- COVID-19 Impact on Reproduction
- Patient Dignity and Privacy
- Global Maternal and Child Health
Massachusetts General Hospital
2021-2023
Brigham and Women's Hospital
2022
Harvard University
2020-2021
Lemuel Shattuck Hospital
2020
Low-dose buprenorphine induction, unlike traditional methods, does not require that individuals experience at least moderate withdrawal before initiation. This technique has been widely used and studied in the general population; however, research pregnancy is limited. We aimed to evaluate obstetric neonatal outcomes after low-dose induction. In this retrospective case series, we reviewed all cases of induction during or within 6 weeks postpartum an urban academic medical center over a...